Ducol Organics
Ducol Organics Q2 FY26: Revenue ₹64.52 Cr, PAT ₹2.82 Cr
Q2 FY26 investor presentation: what the company reported on revenue, margins and capex.
Based on Ducol Organics's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Revenue from operations for H1 FY26 stood at ₹64.52 crore (Consolidated). H1 FY26 EBITDA (consolidated): ₹5.80 crore; EBITDA margin: 8.98% - H1 FY25 EBITDA (standalone comparable): ₹4.41 crore; EBITDA margin: 11.44% - EBITDA margin decreased compared to H1 FY25 (11.44% to 8.98%) due to acquisition-related costs and higher finance costs.
From Ducol Organics's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Revenue from operations for H1 FY26 stood at ₹64.52 crore (Consolidated).
- H1 FY25 standalone revenue was ₹38.58 crore;
- EBITDA (excluding other income) in H1 FY26 was ₹5.80 crore; PAT was ₹2.82 crore.
- Additional finance cost of ₹1.02 crore incurred in H1 FY26 due to acquisition borrowings.
- Bitumag acquisition added to revenue, enabling entry into the waterproofing and construction chemical segments.
- Production capacity increased at Bitumag’s Baroda facility, doubling waterproofing segment capacity.
2 more points from Ducol Organics's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Ducol Organics said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points from Ducol Organics's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Ducol Organics said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Continue your research
What Ducol Organics & Colours Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Dynemic Products Ltd (Q2 FY26)
Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- IVP Ltd (Q2 FY26)
Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Ducol Organics and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Ducol Organics Q2 FY26 results?
Revenue from operations for H1 FY26 stood at ₹64.52 crore (Consolidated). H1 FY26 EBITDA (consolidated): ₹5.80 crore; EBITDA margin: 8.98% - H1 FY25 EBITDA (standalone comparable): ₹4.41 crore; EBITDA margin: 11.44% - EBITDA margin decreased compared to H1 FY25 (11.44% to 8.98%) due to acquisition-related costs and higher finance costs.
What is Ducol Organics share price analysis?
Ducol Organics currently shows a neutral. The stock trades at a P/E of 30.2 with a market cap of ₹219 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Ducol Organics on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
